Publications

2019

Hypoxic drive caused type 3 neovascularization in a preclinical model of exudative age-related macular degeneration.   |   L. Zhang; X. Cui; Y. Han; K.Sophia Park; X. Gao; X. Zhang; Z. Yuan; Y. Hu; C.W. Hsu; X. Li; A.G. Bassuk; V.B. Mahajan; N.K. Wang; S.H. Tsang   |   Details
Comparison of structural progression between ciliopathy and non-ciliopathy associated with autosomal recessive retinitis pigmentosa.   |     |   Details
Novel mutations in the 3-box motif of the BACK domain of KLHL7 associated with nonsyndromic autosomal dominant retinitis pigmentosa.   |     |   Details
Mechanisms of neurodegeneration in a preclinical autosomal dominant retinitis pigmentosa knock-in model with a RhoD190N mutation.   |   S.P. J; L.W.Cui X; T. YT; W. WH; J. S; W. I; H. CW; P. KS; K. S; V. G; B. AG; M. VB; L. CS; T. SH   |   Details
Therapeutic Window for Phosphodiesterase 6-Related Retinitis Pigmentosa.   |   N.K. Wang; V.B. Mahajan; S.H. Tsang   |   Details
Traumatic chorioretinitis sclopetaria: Risk factors, management, and prognosis.   |   C.A. Ludwig; R.A. Shields; D.V. Do; D.M. Moshfeghi; V.B. Mahajan   |   Details
Optical Coherence Tomography Angiography of RPGR-Associated Retinitis Pigmentosa Suggests Foveal Avascular Zone is a Biomarker for Vision Loss.   |   P.H. Tang; R. Jauregui; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
VCAN Canonical Splice Site Mutation is Associated With Vitreoretinal Degeneration and Disrupts an MMP Proteolytic Site.   |   P.H. Tang; G. Velez; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Fundus autofluorescence and ellipsoid zone (EZ) line width can be an outcome measurement in RHO-associated autosomal dominant retinitis pigmentosa.   |   V.K.L. Takahashi; J.T. Takiuti; J.R.L. Carvalho-Jr; C.L. Xu; J.K. Duong; V.B. Mahajan; S.H. Tsang   |   Details
Viral Delivery Systems for CRISPR.   |   C.L. Xu; M.Z.C. Ruan; V.B. Mahajan; S.H. Tsang   |   Details

2018

Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers   |   T. Cabral; L.H. Lima; L.Guilherme Mello; J. Polido; É.P. Correa; A. Oshima; J. Duong; P. Serracarbassa; C.V. Regatieri; V.B. Mahajan;   |   Details
Proteomic analysis of the human retina reveals region-specific susceptibilities to metabolic-and oxidative stress-related diseases   |   G. Velez; D.A. Machlab; P.H. Tang; Y. Sun; S.H. Tsang; A.G. Bassuk; V.B. Mahajan   |   Details
Caring for Hereditary Childhood Retinal Blindness.   |   R. Jauregui; G.Y. Cho; V.K.L. Takahashi; J.T. Takiuti; A.G. Bassuk; V.B. Mahajan; S.H. Tsang   |   Details
Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice.   |   L.P. Evans; E.A. Newell; M. Mahajan; S.H. Tsang; P.J. Ferguson; J. Mahoney; C.D. Hue; E.W. Vogel; B. Morrison; O. Arancio; R. Nichols; A.G. Bassuk; V.B. Mahajan   |   Details
HTRA1, an age-related macular degeneration protease, processes extracellular matrix proteins EFEMP1 and TSP1   |   M.K. Lin; J. Yang; C.Wei Hsu; A. Gore; A.G. Bassuk; L.M. Brown; R. Colligan; J.D. Sengillo; V.B. Mahajan; S.H. Tsang   |   Details
Gene therapy and genome surgery in the retina.   |   J.E. DiCarlo; V.B. Mahajan; S.H. Tsang   |   Details
Deferoxamine-induced electronegative ERG responses.   |   R. Jauregui; K.Sophia Park; A.G. Bassuk; V.B. Mahajan; S.H. Tsang   |   Details
CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.   |   G.Y. Cho; K.A. Schaefer; A.G. Bassuk; S.H. Tsang; V.B. Mahajan   |   Details
Autologous stem cell therapy for inherited and acquired retinal disease   |     |   Details
Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity   |   K.Y. Liu; J.D. Sengillo; G. Velez; R. Jauregui; L.Y. Sakai; I.H. Maumenee; A.G. Bassuk; V.B. Mahajan; S.H. Tsang   |   Details

Pages